Turn Therapeutics Inc. (TTRX) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Sep 18Sep 23Sep 28Oct 1Oct 6Oct 9Oct 14Oct 19

Key dataOct 19, 2026

Open$10.72

From 52W high−29.99%

Volume29290.00

Market cap$326.15M

P/E (TTM)—

P/S (TTM)—

Div yield—

Key dataOct 19, 2026

Open

$10.72

From 52W high

−29.99%

Volume

29290.00

Market cap

$326.15M

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−77.3x

P/E (TTM)

—

RSI (14)

42.9

MomentumView details →

1D Return

+1.61%

YTD Return

+173.35%

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

—

EV/EBITDA

−77.3x

EV/Sales

—

P/S (TTM)

—

P/B (TTM)

474.8x

ProfitabilityView details →

Gross Margin

—

Net Margin

—

EBITDA Margin

—

ROE (TTM)

−1229.58%

ROA (TTM)

−49.80%

Asset Turnover

0.00x

GrowthView details →

Revenue YoY

—

EPS YoY

—

FCF YoY

—

Revenue CAGR 3Y

—

EPS CAGR 3Y

−76.92%

EBITDA YoY

—

MomentumView details →

1D Return

+1.61%

YTD Return

+173.35%

1Y Return

+118.02%

RSI (14)

42.9

vs 50D SMA

−7.31%

vs 200D SMA

+59.84%

Capital & dividendView details →

Debt/Equity

8.91x

Current Ratio

1.19x

Quick Ratio

1.19x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

−$0.20

EPS Surprise

−900.00%

Beats (12Q)

0/12

Next Q EPS Est

−$0.12

Avg Surprise (4Q)

−342.16%

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

0.00

Net Income (TTM)

−8.45M

Op. CF (TTM)

−4.32M

Next earningsNov 12, 2026 →

Latest newsMore news →

Turn Therapeutics announced new peer-reviewed research showing its product GX-03 selectively reduces key drivers of skin inflammation and itch.61d ago

Turn Therapeutics Inc. completed the full cashless exercise of a warrant to purchase its common stock, issuing 579,664 shares of common stock to GEM Global Yield LLC SCS and GEM Yield Bahamas Limited at an exercise price of $5.03 per share, relying on the Section 4(a)(2) exemption for accredited investors.63d ago

Similar companies

Enanta Pharmaceuticals, Inc.ENTA B&K Corporation Limited02396.HK Nautilus Biotechnology, Inc.NAUT Opus Genetics, Inc.IRD Relmada Therapeutics, Inc.RLMD Cutia Therapeutics02487.HK Find similar companies →

Latest newsMore news →

Turn Therapeutics announced new peer-reviewed research showing its product GX-03 selectively reduces key drivers of skin inflammation and itch.61d ago Turn Therapeutics Inc. completed the full cashless exercise of a warrant to purchase its common stock, issuing 579,664 shares of common stock to GEM Global Yield LLC SCS and GEM Yield Bahamas Limited at an exercise price of $5.03 per share, relying on the Section 4(a)(2) exemption for accredited investors.63d ago